Search / Trial NCT06227143

Anesthesia Depth During Opioid Free Anesthesia

Launched by REGION HALLAND · Jan 18, 2024

Trial Information

Current as of December 22, 2024

Completed

Keywords

ClinConnect Summary

Patients who undergo general anaesthesia are more or less extensively monitored, with the sole purpose of surveilling depth of anesthesia and nociception. Parameters such as heart rate, blood pressure, pupillary size and sweating has historically been used as predictive markers for this surveillance. However, these clinical parameters have low predictive capacity and there is a tendency to overdue perioperative sedation and misinterpret sympathetically derived reactions as pain. This could lead to higher incidence of postoperative delirium and opioid induced hyperalgesia. On the contrary, a...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Elective laparoscopic surgery
  • Adult patients
  • Ability to accomodate verbal and written information in swedish
  • Voluntary
  • Exclusion Criteria:
  • Pregnancy
  • Intolerance to NSAID

Trial Officials

Krister Mogianos, MD

Principal Investigator

Region Halland

About Region Halland

Region Halland is a leading healthcare authority in Sweden, dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to high ethical standards and rigorous scientific methodologies, Region Halland collaborates with researchers, healthcare professionals, and academic institutions to facilitate groundbreaking studies across various therapeutic areas. By prioritizing patient safety and engagement, Region Halland aims to contribute valuable insights to the medical community and enhance the quality of healthcare services within the region and beyond.

Locations

Halmstad, Halland, Sweden

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0